top of page
maximon Final.png
Cross.png

News

Updates From Maximon - September

26.09.2023

Maximon

Read our monthly newsletter.

Image-empty-state.png

Updates From Maximon - August

29.08.2023

Maximon

Read our monthly newsletter.

Image-empty-state.png

Investments in anti-aging: In longevity the new big businesses of the billionaires

16.08.2023

Protothema.gr

Longevity and Maximon are featured on Protothema, the biggest Greek news site

Image-empty-state.png

Updates From Maximon - July

26.07.2023

Maximon

Read our monthly newsletter.

Image-empty-state.png

Avea secured $5M to accelerate its growth

04.07.2023

Longevity.Technology

Maximon venture Avea Life has successfully closed a funding round by raising an impressive $5 million. With this significant boost, Avea Life is set to accelerate its growth across Europe and establish its presence in the APAC market.

Image-empty-state.png

Updates From Maximon - June

28.06.2023

Maximon

Read our monthly newsletter.

Image-empty-state.png

Maximon increases investment volume for Longevity start-ups to CHF 30 million and enlarges its Board of Directors

23.06.2023

Maximon

Maximon - The Company Builder is providing additional capital for the construction of Longevity companies. In addition, the Board of Directors will be further reinforced with Christoph Schwarzenbach.

Image-empty-state.png

Updates From Maximon - May

31.05.2023

Maximon

Read our monthly newsletter.

Image-empty-state.png

Biolytica secured CHF 5.25 million in funding from Maximon

03.05.2023.

Longevity.Technology

Maximon fully supports Biolytica on their mission to build out personalised health accessible to everyone. Their innovative approach to healthcare is paving the way for a brighter, more inclusive future.

Image-empty-state.png

Updates From Maximon - March & April

18.04.2023

Maximon

Read our monthly newsletter.

Image-empty-state.png

Maximon Longevity Prize Applications are Open!

06.04.2023.

Longevity.Technology

Maximon's Longevity Prize 2023 is now accepting applications for translational longevity research projects! If you have an innovative idea that can help extend the human lifespan, we want to hear from you.

Image-empty-state.png

Longevity is near – and what you can do with it | Tobias Reichmuth | TEDxBielBienne

03.04.2023.

TEDxBielBienne

Tobias Reichmuth explores the concept of longevity, discussing how our increasing lifespan presents both challenges and opportunities for society. He offers insights into the latest scientific and technological advancements in anti-aging research and how they could transform the way we live our lives.

Image-empty-state.png

Marc P. Bernegger on the emerging field of longevity

27.03.2023.

BFI Capital Group

Marc P. Bernegger explains how longevity has been transformed from a futurist niche to a scientifically backed Megatrend and how with his latest endeavour, Maximon, he's is capitalizing it.

Image-empty-state.png

Updates from Maximon - February

21.03.2023.

Maximon

Read our monthly newsletter.

Image-empty-state.png

Traum vom langen Leben: Start-ups wollen Schweiz zum Hotspot des Trends machen

18.03.2023.

Handelsblatt

Immer mehr Healthtech-Firmen zieht es in die Schweiz. Der gute Zugang zu Kunden und Kapital hilft Firmen, auch in Deutschland zu expandieren.

Image-empty-state.png

Forever Young

23.02.2023.

Manager Magazin

„Forever Young“: Tech elite and venture capitalists have declared war on death. Thanks to billions invested in promising research results, mankind's greatest dream, eternal life, seems more tangible than ever.

Image-empty-state.png

Länger Gesünder Leben

14.02.2023.

Transkript.de

Longer Healthier Life: Read the Transkript article from the authors Georg Kääb and Gwendolyn Dorow about longevity, life extension, rejuvenation and how it is not a field just for esoterics anymore, as more and more investors are getting involved.

Image-empty-state.png

Updates from Maximon - January

07.02.2023.

Maximon

Read our monthly newsletter for the month of January.

Image-empty-state.png

Longevity sector focus at Davos

24.01.2023.

Longevity.Technology

Longevity remains key focus at World Economic Forum 2023.

Image-empty-state.png

Longevity takes over Davos (again)

24.01.2023.

Moneycab

Longevity stays in the limelight on the streets of Davos for the second time during this year’s World Economic Forum (WEF). The world is growing – and aging – at a rapid rate, and nearly a third of the world’s population will be over 60 years old by 2050.

Image-empty-state.png

Updates from Maximon - December

04.01.2023.

Maximon

Read our monthly newsletter.

Image-empty-state.png

Updates from Maximon - November

07.12.2022.

Maximon

Read our monthly newsletter.

Image-empty-state.png

Inside the billion-dollar meeting for the mega-rich who want to live forever

16.11.2022.

MIT Technology Review

Hope, hype, and self-experimentation collided at an exclusive conference for ultra-rich investors who want to extend their lives past 100. I went along for the ride.

Image-empty-state.png

Tobias Reichmuth – the longevity market starts now

04.11.2022.

Longevity.Technology

Dr Tobias Reichmuth talks taking hardcore science to market without biotech approval risk and the catalyst that is translational research.

Image-empty-state.png

Updates from Maximon

26.10.2022.

Maximon

Read our monthly newsletter.

Image-empty-state.png

Meet the company builders that think they can reverse ageing

10.10.2022.

Sifted

Longevity research has often focused on combatting one specific aspect of ageing, like regenerating the liver or the brain. But recently, there’s been a shift towards looking for the silver bullet for all age-related diseases.

Image-empty-state.png

‘We want to bring the concept of longevity to life’

04.10.2022.

Longevity.Technology

Maximon CSO talks clinics, diagnostics, and why longevity is about much more than drug development.

Image-empty-state.png

Can we find ways to live beyond 100? Millionaires are betting on it.

30.09.2022.

MIT Technology Review

At a luxury resort in the Swiss Alps, wealthy investors and scientists are cooking up plans to push the limits of the human lifespan.

Image-empty-state.png

Eye-level longevity – why breakthrough research is top investment opportunity

23.09.2022.

Longevity.Technology

Our pioneers of longevity discuss where the field can be monetised and the breadth of the total addressable market.

Image-empty-state.png

Updates from Maximon - August

06.09.2022.

Maximon

Read our monthly newsletter for the month of August.

Image-empty-state.png

Datenanalysen und langes Leben

02.09.2022.

Handelszeitung

Handelszeitung published an interesting story about extending the human lifespan mentioning Maximon, Avea Life, Biolytica and our future longevity ventures.

Image-empty-state.png

Elisabeth Roider joins Maximon as a Partner & Chief Scientific and Medical Officer

29.08.2022.

Longevity.Technology

Driven by the mission to identify and solve the most relevant medical and public health problems, Elisabeth Roider joins Maximon as a Partner & Chief Scientific and Medical Officer.

Image-empty-state.png

Updates from Maximon - July

03.08.2022.

Maximon

Read our monthly newsletter for the month of July.

Image-empty-state.png

Updates from Maximon - June

05.07.2022.

Maximon

Read our monthly newsletter for the month of June.

Image-empty-state.png

Updates from Maximon - May

07.06.2022.

Maximon

Read our monthly newsletter for the month of May.

Image-empty-state.png

Longevity takes over Davos – and has Gstaad in its sights

06.06.2022.

Longevity.Technology

Longevity was one of the most talked about industries on the streets of Davos during this year’s World Economic Forum (WEF), one of the largest gatherings of the world’s financial and political elite.

Image-empty-state.png

AVEA included in the “Startups to watch in the DACH Region” list by Sifted

03.06.2022.

Sifted

AVEA was included in the “Startups to watch in the DACH Region” list by Sifted.

Image-empty-state.png

CHF2.5 million to support the growth of longevity start-up AVEA

01.06.2022.

startupticker.hr

Our first longevity venture, Avea Life, announces the closing of a 2.5 million CHF seed financing round.

Image-empty-state.png

Updates from Maximon - April

03.05.2022.

Maximon

Read our monthly newsletter for the month of April

Image-empty-state.png

Ten simple rules for building a successful science start-up

07.04.2022

Plos Computational Biology

A peer-reviewed publication with a mix of thoughts and experiences from our Founding Partner Dr. Tobias Reichmuth and our Scientific Advisor Prof. Dr. Collin Y. Ewald.

Image-empty-state.png

Updates from Maximon - March

05.04.2022.

Maximon

Read our monthly newsletter for the month of March.

Image-empty-state.png

New innovation longevity research prize launched

01.03.2022

longevity.technology

The most innovative longevity research could bag 50k CHF thanks to Maximon, which is launching its first Prize for Translational Research in Longevity.

Image-empty-state.png

Longevity: Der HealthTech Trend, auf den der Company Builder Maximon setzt

01.02.2022

Trending Topics

Wer ein neues Schlagwort in der HealthTech-Branche sucht, wird bei Longevity fündig. Kleine wie große Unternehmen suchen verstärkt nach Medikamenten, Therapien und digitalen Mitteln, um die Langlebigkeit von Menschen in überalterten Gesellschaften wie Europa oder Japan zu verbessern.
Mit Maximon, gegründet von den Schweizer Unternehmern Tobias Reichmuth und Marc Bernegger, gibt es einen neuen Company Builder, der auf Longevity-Startups setzt.

Image-empty-state.png

European investors have a new obsession: longevity

21.12.2021

Sifted

Imagine a world where the average life expectancy is well over 100 years (and doesn’t involve spending 30 years in a care home). Imagine a world where — thanks to scientific findings made over the last five years — there’s a cure for ageing.

Image-empty-state.png

Sophie Chabloz darüber, welche Stoffe das Altern bremsen können

11.10.2021

Handelszeitung

Die Gesundheitswissenschafterin Sophie Chabloz über Nahrungsergänzungsmittel, die verjüngen können. Sie erzählt, was sie selber nimmt und wie es wirkt.

Image-empty-state.png

Maximon launches 100 million Longevity Co-Investment Fund

07.10.2021

longevity.technology

The Longevity Co-Investment Fund finances longevity-focussed start-up companies launched by company-builder Maximon.

Image-empty-state.png

First companies benefit from Maximon's Longevity Co-Investment Fund

07.10.2021

startupticker.ch

The newly launched CHF 100 million Fund finances longevity-focussed start-ups founded by Swiss company builder Maximon. The Fund’s first investments include Zug based companies AVEA and Biolytica.

Image-empty-state.png

Tobias Reichmuth, Mitgründer Maximon, im Interview

10.09.2021

moneycab

Herr Reichmuth, Longevity, oder Langlebigkeit, tönt ein wenig nach der Suche des heiligen Grals, dem Wunsch, ewig jung zu sein. Wollen Sie das ewige Leben ermöglichen?

Image-empty-state.png

The Rising Importance of Crypto in Aging Research

23.07.2021

lifespan.io

The cryptocurrency world is colliding with aging research and life extension and could change how research gets funded.

Image-empty-state.png

Maximon gründet den weltweit ersten Longevity Company Builder

11.03.2021

moneycab.com

Zug – Maximon ist ein neuer Company Builder mit Sitz in der Schweiz, der das Ziel verfolgt, den “Health-Span”, also die Zeitspanne ohne Altersleiden und Krankheiten, zu verlängern und Menschen eine fitte, gesunde und glückliche Langlebigkeit zu ermöglichen.

Image-empty-state.png

Can finance give Old Father Time a run for his money?

13.03.2021

swissinfo.ch

It looks like longevity is in it for the long run in Switzerland. Financiers are serious about funding the science of longer and healthier lives. The Swiss “Longevity Valley” dream also has political backing.

Image-empty-state.png

Serial Entrepreneurs gründen Company Builder mit Fokus auf Langlebigkei

09.03.2021

startupticker.ch

Maximon soll in den kommenden Jahren systematisch Startups hervorbringen, deren Produkte die Zeitspanne ohne Altersleiden und Krankheiten verlängern. Das vierköpfige Gründungsteam hat bereits Millionen investiert und arbeitet an ersten Projekten.

Image-empty-state.png

Maximon builds new longevity companies from scratch

08.03.2021

lifeforever.club

“The real difference is that we really build the companies from scratch,” - Tobias Reichmuth, co-founder of Maximon.

Image-empty-state.png

Swiss longevity company builder launches

07.03.2021

longevity.technology

Swiss-based Maximon already moving forward with companies focused on precision supplements and personalised longevity advice.

Image-empty-state.png

The economic value of targeting aging

05.07.2021

Nature Aging

A recent paper written by economist Martin Ellison of Oxford University. biologist David Sinclair of Harvard Medical School, and economist Andrew Scott from London Business School, calculates that an intervention that successfully slows down biological aging—lowering mortality and frailty at each age, such that U.S. life expectancy would increase by just one year—is estimated to be worth $37 trillion in net present value terms. That’s the equivalent of around $700 billion annually, more than 3 percent of the country’s entire GDP.

Image-empty-state.png

Avea secured $5M to accelerate its growth

04.07.2023

Longevity.Technology

Maximon venture Avea Life has successfully closed a funding round by raising an impressive $5 million. With this significant boost, Avea Life is set to accelerate its growth across Europe and establish its presence in the APAC market.

Image-empty-state.png

Updates From Maximon - September

26.09.2023

Read our monthly newsletter.

Read More
Image-empty-state.png

Don't stop me now! ™

© Maximon 2023

All Rights Reserved.

Thanks for submitting!

bottom of page